Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ralf Kiesling"'
Autor:
Ralf Kiesling, Thomas Zeltner, Anja Kraemer, Albert Zeller, Julian Thoma, Christian Fackler, Viktor Pfeifer
Publikováno v:
Angewandte Chemie International Edition. 60:26671-26676
Palladium nanoparticles (PdNp) were revealed as an efficient hydrogen isotope exchange catalyst for the deuterium and tritium labeling of benzylic positions of complex molecules. A practical way to obtain small palladium nanoparticles and to apply th
Autor:
Etienne, Levernier, Kevin, Tatoueix, Sébastien, Garcia-Argote, Viktor, Pfeifer, Ralf, Kiesling, Edmond, Gravel, Sophie, Feuillastre, Grégory, Pieters
Publikováno v:
JACS Au. 2(4)
Facilitating access to deuterated and tritiated complex molecules is of paramount importance due to the fundamental role of isotopically labeled compounds in drug discovery and development. Deuterated analogues of drugs are extensively used as intern
Autor:
Viktor Pfeifer, Thomas Zeltner, Christian Fackler, Anja Kraemer, Julian Thoma, Albert Zeller, Ralf Kiesling
Publikováno v:
Angewandte Chemie. 133:27072-27072
Autor:
Viktor Pfeifer, Thomas Zeltner, Christian Fackler, Anja Kraemer, Julian Thoma, Albert Zeller, Ralf Kiesling
Publikováno v:
Angewandte Chemie International Edition. 60:26868-26868
Autor:
Ralf Kiesling, Stefan Aßfalg, Chris H. Senanayake, Nina C. Gonnella, Max Chevliakov, Matt Hrapchak, Bachir Latli, Carl A. Busacca, Scot Campbell
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 59:648-656
Dabigatran etexilate or pradaxa, a novel oral anticoagulant, is a reversible, competitive, direct thrombin inhibitor. It is used to prevent strokes in patients with atrial fibrillation and the formation of blood clots in the veins (deep venous thromb
Autor:
Bachir, Latli, Ralf, Kiesling, Stefan, Aßfalg, Max, Chevliakov, Matt, Hrapchak, Scot, Campbell, Nina, Gonnella, Carl A, Busacca, Chris H, Senanayake
Publikováno v:
Journal of labelled compoundsradiopharmaceuticals. 59(14)
Dabigatran etexilate or pradaxa, a novel oral anticoagulant, is a reversible, competitive, direct thrombin inhibitor. It is used to prevent strokes in patients with atrial fibrillation and the formation of blood clots in the veins (deep venous thromb
Autor:
Peter Sieger, Ines Kollak, Ralf Kiesling, Michael P. Pieper, Andreas Schnapp, Paola Casarosa, Tobias Kiechle, Angela Ostermann, Florian Gantner
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 337:600-609
β 2 -Adrenoceptor (β 2 -AR) agonists are powerful bronchodilators and play a pivotal role in the management of pulmonary obstructive diseases, such as asthma and chronic obstructive pulmonary disease. Although these agents first were used many year
Autor:
Etienne Levernier, Kevin Tatoueix, Sébastien Garcia-Argote, Viktor Pfeifer, Ralf Kiesling, Edmond Gravel, Sophie Feuillastre, Grégory Pieters
Publikováno v:
JACS Au. 2(4):801-808